Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis. (2020)
Attributed to:
Understanding acquisition and evolution of antifungal resistance in chronic respiratory disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1183/13993003.02554-2020
PubMed Identifier: 32703771
Publication URI: http://europepmc.org/abstract/MED/32703771
Type: Journal Article/Review
Volume: 56
Parent Publication: The European respiratory journal
Issue: 4
ISSN: 0903-1936